中医药辅助治疗哮喘合并过敏性鼻炎的疗效观察

摘要

OBJECTIVE:To observe the clinical efficacy and complications of TCM in the adjuvant treatment of asthma and allergic rhinitis. METHODS:160 patients with asthma and allergic rhinitis were divided into control group and observation group according to the visiting order of odd or even,80 cases in each group. Control group received basic western medicine,such as lo-ratadine and budesonide used for allergic rhinitis,salmeterol/fluticasone and leukotriene for asthma;observation group additionally received TCM(inline treatment + external treatment),the treatment course was 3 months. Clinical efficacy and complications in 2 groups were compared. RESULTS:The observation group had 2 cases of fall-off patients,and the control group had 3 cases. The total effective rate in observation group was 97.43%,which was higher than control group(74.03%),the difference was statistical-ly significant (P<0.05). The incidence of complications in observation group was 8.97%,which was lower than control group (19.48%),the difference was statistically significant(P<0.05). CONCLUSIONS:TCM can obviously relieve clinical symptoms, improve efficacy and reduce the incidence of complications in the adjuvant treatment of patients with asthma and allergic rhinitis.%目的：观察中医药辅助治疗哮喘合并过敏性鼻炎的临床疗效及并发症。方法：160例哮喘合并过敏性鼻炎的患者按就诊顺序单双号分成对照组和观察组，各80例。对照组患者行基本西医诊治，如采用氯雷他定和布地奈德治疗过敏性鼻炎，采用沙美特罗替卡松和孟鲁司特钠治疗哮喘等；观察组患者在对照组治疗基础上辅以中医药治疗（内治法+外治法）。两组疗程均为3个月。比较两组患者的临床疗效和并发症发生情况。结果：观察组、对照组分别有2、3例脱落病例。观察组患者的总有效率为97.43％，明显高于对照组的74.03％，两组比较差异有统计学意义（P＜0.05）。观察组患者的并发症发生率为8.97％，明显低于对照组的19.48％，两组比较差异有统计学意义（P＜0.05）。结论：中医药辅助治疗哮喘合并过敏性鼻炎，可明显减轻患者的临床症状，提高疗效，并减少并发症发生几率。